Suppr超能文献

铜及其配合物在心血管疾病中的作用。

Role of copper and its complexes in cardiovascular diseases.

作者信息

Zhu Wenjun, Zhang Yiyue, Luo Xiuju, Peng Jun

机构信息

Department of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410078.

Department of Laboratory Medicine, Third Xiangya Hospital, Central South University, Changsha 410013, China.

出版信息

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Nov 28;48(11):1731-1738. doi: 10.11817/j.issn.1672-7347.2023.230159.

Abstract

Copper is a trace element essential for the maintenance of normal physiological functions in cardiovascular system, and its transport and metabolisms are regulated by various copper proteins such as copper-based enzymes, copper chaperones and copper transporters. The disturbance of copper level or abnormal expression of copper proteins are closely associated with the development of cardiovascular diseases such as atherosclerosis, hypertension, ischemic heart disease, myocardial hypertrophy and heart failure. Thus, intervention of copper ion signaling pathways is expected to be an effective measure for treating cardiovascular diseases. Some copper complexes, such as trientine, copper-aspirinate complex and copper (II) diethyldithiocarbamate, have been found to play a role in the prevention and treatment of cardiovascular diseases and possess potential prospects. Exploring the role of copper in maintaining normal cardiovascular status and the potential application of copper complexes in the treatment of cardiovascular diseases may lay a foundation for finding new targets for prevention and treatment of various cardiovascular diseases, and provide new ideas for clinical treatment of cardiovascular diseases.

摘要

铜是维持心血管系统正常生理功能所必需的微量元素,其运输和代谢受多种铜蛋白调控,如铜基酶、铜伴侣蛋白和铜转运体。铜水平的紊乱或铜蛋白的异常表达与动脉粥样硬化、高血压、缺血性心脏病、心肌肥大和心力衰竭等心血管疾病的发生密切相关。因此,干预铜离子信号通路有望成为治疗心血管疾病的有效措施。一些铜配合物,如曲恩汀、阿司匹林铜配合物和二乙基二硫代氨基甲酸铜(II),已被发现对心血管疾病的防治具有作用,并具有潜在前景。探索铜在维持心血管正常状态中的作用以及铜配合物在心血管疾病治疗中的潜在应用,可能为寻找各种心血管疾病防治的新靶点奠定基础,并为心血管疾病的临床治疗提供新思路。

相似文献

1
Role of copper and its complexes in cardiovascular diseases.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Nov 28;48(11):1731-1738. doi: 10.11817/j.issn.1672-7347.2023.230159.
2
Copper transporters and copper chaperones: roles in cardiovascular physiology and disease.
Am J Physiol Cell Physiol. 2018 Aug 1;315(2):C186-C201. doi: 10.1152/ajpcell.00132.2018. Epub 2018 Jun 6.
3
Creatine and creatine analogues in hypertension and cardiovascular disease.
Cochrane Database Syst Rev. 2011 Nov 9;2011(11):CD005184. doi: 10.1002/14651858.CD005184.pub2.
4
The loss of copper is associated with the increase in copper metabolism MURR domain 1 in ischemic hearts of mice.
Exp Biol Med (Maywood). 2018 May;243(9):780-785. doi: 10.1177/1535370218773055.
5
Copper ions: The invisible killer of cardiovascular disease (Review).
Mol Med Rep. 2024 Nov;30(5). doi: 10.3892/mmr.2024.13334. Epub 2024 Sep 20.
6
Ferroptosis in cardiovascular disease.
Biomed Pharmacother. 2024 Jan;170:116057. doi: 10.1016/j.biopha.2023.116057. Epub 2023 Dec 29.
7
Selective divalent copper chelation for the treatment of diabetes mellitus.
Curr Med Chem. 2012;19(17):2828-60. doi: 10.2174/092986712800609715.
9
The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease.
Biomed Pharmacother. 2023 Jul;163:114830. doi: 10.1016/j.biopha.2023.114830. Epub 2023 May 8.
10
Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites.
Dalton Trans. 2013 May 7;42(17):6161-70. doi: 10.1039/c2dt32252h. Epub 2012 Dec 3.

本文引用的文献

1
A druggable copper-signalling pathway that drives inflammation.
Nature. 2023 May;617(7960):386-394. doi: 10.1038/s41586-023-06017-4. Epub 2023 Apr 26.
2
Copper chaperone antioxidant 1: multiple roles and a potential therapeutic target.
J Mol Med (Berl). 2023 May;101(5):527-542. doi: 10.1007/s00109-023-02311-w. Epub 2023 Apr 5.
3
Cuproptosis: mechanisms and links with cancers.
Mol Cancer. 2023 Mar 7;22(1):46. doi: 10.1186/s12943-023-01732-y.
6
Practical insights into chronic management of hepatic Wilson's disease.
World J Clin Cases. 2022 May 16;10(14):4334-4347. doi: 10.12998/wjcc.v10.i14.4334.
7
Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology.
Diabetes Metab Syndr Obes. 2022 Mar 3;15:695-711. doi: 10.2147/DMSO.S346648. eCollection 2022.
8
Structure of the Wilson disease copper transporter ATP7B.
Sci Adv. 2022 Mar 4;8(9):eabl5508. doi: 10.1126/sciadv.abl5508.
9
The Role of COA6 in the Mitochondrial Copper Delivery Pathway to Cytochrome Oxidase.
Biomolecules. 2022 Jan 13;12(1):125. doi: 10.3390/biom12010125.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验